Dosimetric evaluation of magnetic resonance imaging-guided adaptive radiation therapy in pancreatic cancer by extent of re-contouring of organs-at-risk

被引:2
作者
Song, Jun Yeong [1 ,2 ]
Chie, Eui Kyu [1 ,2 ]
Kang, Seong-Hee [1 ]
Jeon, Yeon-Jun [3 ]
Ko, Yoon-Ah [3 ]
Kim, Dong-Yun [2 ,4 ]
Kang, Hyun-Cheol [1 ,2 ]
机构
[1] Seoul Natl Univ Hosp, Dept Radiat Oncol, 101 Daehak Ro, Seoul 03080, South Korea
[2] Seoul Natl Univ, Dept Radiat Oncol, Coll Med, Seoul, South Korea
[3] Seoul Natl Univ, Coll Med, Seoul, South Korea
[4] Kyung Hee Univ Hosp Gangdong, Dept Radiat Oncol, Seoul, South Korea
来源
RADIATION ONCOLOGY JOURNAL | 2022年 / 40卷 / 04期
关键词
Pancreatic neoplasms; Radiotherapy; Radiosurgery; Adaptation; Organs at risk; STEREOTACTIC BODY RADIOTHERAPY; GEMCITABINE; CHEMORADIOTHERAPY; TOXICITY; SURVIVAL; TRIAL; SBRT;
D O I
10.3857/roj.2022.00332
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: The safety of online contouring and planning for adaptive radiotherapy is unknown. This study aimed to evaluate the dosimetric difference of the organ-at-risk (OAR) according to the extent of contouring in stereotactic magnetic resonance image-guided adaptive RT (SMART) for pancreatic cancer.Materials and Methods: We reviewed the treatment plan data used for SMART in patients with pancreatic cancer. For the online contouring and planning, OARs within 2 cm from the planning target volume (PTV) in the craniocaudal direction were re-controlled daily at the attending physician's discretion. The entire OARs were re-contoured retrospectively for data analysis. We termed the two contouring methods the Rough OAR and the Full OAR, respectively. The proportion of dose constraint violation and other dosimetric parameters was analyzed.Results: Nineteen patients with 94 fractions of SMART were included in the analysis. The dose constraint was violated in 10.6% and 43.6% of the fractions in Rough OAR and Full OAR methods, respectively (p = 0.075). Patients with a large tumor, a short distance from gross tumor volume (GTV) to OAR, and a tumor in the body or tail were associated with more occult dose constraint violations- large tumor (p = 0.027), short distance from GTV to OAR (p = 0.061), tumor in body or tail (p = 0.054). No dose constraint violation occurred outside 2 cm from the PTV.Conclusion: More occult dose constraint violations can be found by the Full OAR method in patients with pancreatic cancer with some clinical factors in the online re-planning for SMART. Re-contouring all the OARs would be helpful to detect occult dose constraint violations in SMART planning. Since the dosimetric profile of SMART cannot be represented by a single fraction, patient selection for the Full OAR method should be weighted between the clinical usefulness and the time and workforce required.
引用
收藏
页码:242 / 250
页数:9
相关论文
共 50 条
  • [31] Ablative 5-Fraction Stereotactic Magnetic Resonance-Guided Radiation Therapy With On-Table Adaptive Replanning and Elective Nodal Irradiation for Inoperable Pancreas Cancer
    Chuong, Michael D.
    Bryant, John
    Mittauer, Kathryn E.
    Hall, Matthew
    Kotecha, Rupesh
    Alvarez, Diane
    Romaguera, Tino
    Rubens, Muni
    Adamson, Sonia
    Godley, Andrew
    Mishra, Vivek
    Luciani, Gustavo
    Gutierrez, Alonso N.
    [J]. PRACTICAL RADIATION ONCOLOGY, 2021, 11 (02) : 134 - 147
  • [32] Optimal timing of organs-at-risk-sparing adaptive radiation therapy for head-and-neck cancer under re-planning resource constraints
    Nosrat, Fatemeh
    Dede, Cem
    Mccullum, Lucas B.
    Garcia, Raul
    Mohamed, Abdallah S. R.
    Scott, Jacob G.
    Bates, James E.
    Mcdonald, Brigid A.
    Wahid, Kareem A.
    Naser, Mohamed A.
    He, Renjie
    Karagoz, Aysenur
    Moreno, Amy C.
    Dijk, Lisanne V. van
    Brock, Kristy K.
    Heukelom, Jolien
    Hosseinian, Seyedmohammadhossein
    Hemmati, Mehdi
    Schaefer, Andrew J.
    Fuller, Clifton D.
    [J]. PHYSICS & IMAGING IN RADIATION ONCOLOGY, 2025, 33
  • [33] Multi-Institutional Outcomes of Patients Aged 75 years and Older With Pancreatic Ductal Adenocarcinoma Treated With 5-Fraction Ablative Stereotactic Magnetic Resonance Image-Guided Adaptive Radiation Therapy (A-SMART)
    Bryant, J. M.
    Palm, Russell F.
    Herrera, Roberto
    Rubens, Muni
    Hoffe, Sarah E.
    Kim, Dae Won
    Kaiser, Adeel
    Ucar, Antonio
    Fleming, Jason
    De Zarraga, Fernando
    Hodul, Pamela
    Aparo, Santiago
    Asbun, Horacio
    Malafa, Mokenge
    Jimenez, Ramon
    Denbo, Jason
    Frakes, Jessica M.
    Chuong, Michael D.
    [J]. CANCER CONTROL, 2023, 30
  • [34] Dose evaluations of organs at risk and predictions of gastrointestinal toxicity after re-irradiation with stereotactic body radiation therapy for pancreatic cancer by deformable image registration
    Cao, Yangsen
    Zhu, Xiaofei
    Yu, Chunshan
    Jiang, Lingong
    Sun, Yongjian
    Guo, Xueling
    Zhang, Huojun
    [J]. FRONTIERS IN ONCOLOGY, 2023, 12
  • [35] Identifying risk characteristics using failure mode and effect analysis for risk management in online magnetic resonance-guided adaptive radiation therapy
    Nishioka, Shie
    Okamoto, Hiroyuki
    Chiba, Takahito
    Sakasai, Tatsuya
    Okuma, Kae
    Kuwahara, Junichi
    Fujiyama, Daisuke
    Nakamura, Satoshi
    Iijima, Kotaro
    Nakayama, Hiroki
    Takemori, Mihiro
    Tsunoda, Yuuki
    Kaga, Keita
    Igaki, Hiroshi
    [J]. PHYSICS & IMAGING IN RADIATION ONCOLOGY, 2022, 23 : 1 - 7
  • [36] Long-Term Outcomes of Partial Prostate Treatment With Magnetic Resonance Imaging-Guided Brachytherapy for Patients With Favorable-Risk Prostate Cancer
    King, Martin T.
    Nguyen, Paul L.
    Boldbaatar, Ninjin
    Tempany, Clare M.
    Cormack, Robert A.
    Beard, Clair J.
    Hurwitz, Mark D.
    Suh, W. Warren
    D'Amico, Anthony V.
    Orio, Peter F., III
    [J]. CANCER, 2018, 124 (17) : 3528 - 3535
  • [37] A Multi-Institutional Phase 2 Trial of Ablative 5-Fraction Stereotactic Magnetic Resonance-Guided On-Table Adaptive Radiation Therapy for Borderline Resectable and Locally Advanced Pancreatic Cancer
    Parikh, Parag Jitendra
    Lee, Percy
    Low, Daniel A.
    Kim, Joshua
    Mittauer, Kathryn E.
    Bassetti, Michael F.
    Glide-Hurst, Carri K.
    Raldow, Ann C.
    Yang, Yingli
    Portelance, Lorraine
    Padgett, Kyle R.
    Zaki, Bassem
    Zhang, Rongxiao
    Kim, Hyun
    Henke, Lauren E.
    Price, Alex T.
    Mancias, Joseph D.
    Williams, Christopher L.
    Ng, John
    Pennell, Ryan
    Pfeffer, M. Raphael
    Levin, Daphne
    Mueller, Adam C.
    Mooney, Karen E.
    Kelly, Patrick
    Shah, Amish P.
    Boldrini, Luca
    Placidi, Lorenzo
    Fuss, Martin
    Chuong, Michael D.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2023, 117 (04): : 799 - 808
  • [38] Clinical experience and cost evaluation of magnetic resonance imaging-only workflow in radiation therapy planning of prostate cancer
    Keyrilainen, Jani
    Sjoblom, Olli
    Turnbull-Smith, Sonja
    Hovirinta, Taru
    Minn, Heikki
    [J]. PHYSICS & IMAGING IN RADIATION ONCOLOGY, 2021, 19 : 66 - 71
  • [39] Adaptive Volumetric-Modulated Arc Radiation Therapy for Head and Neck Cancer: Evaluation of Benefit on Target Coverage and Sparing of Organs at Risk
    Franzese, Ciro
    Tomatis, Stefano
    Bianchi, Sofia Paola
    Pelizzoli, Marco
    Teriaca, Maria Ausilia
    Badalamenti, Marco
    Comito, Tiziana
    Clerici, Elena
    Franceschini, Davide
    Navarria, Pierina
    Di Cristina, Luciana
    Dei, Damiano
    Galdieri, Carmela
    Reggiori, Giacomo
    Mancosu, Pietro
    Scorsetti, Marta
    [J]. CURRENT ONCOLOGY, 2023, 30 (03) : 3344 - 3354
  • [40] Impact of multiparametric magnetic resonance imaging on risk group assessment of patients with prostate cancer addressed to external beam radiation therapy
    Pullini, Serena
    Signor, Marco Andrea
    Pancot, Martina
    Zuiani, Chiara
    Bazzocchi, Massimo
    Fongione, Sandro
    Girometti, Rossano
    [J]. EUROPEAN JOURNAL OF RADIOLOGY, 2016, 85 (04) : 764 - 770